Mesothelioma.com Resources for Patients and their Families
Request Free Guide

Mesothelioma Doctors

Ryan Gentzler, MD

Dr. Gentzler
Charlottesville, VA

Dr. Ryan Gentzler

Medical Oncologist

University of Virginia Health System

Emily Couric Clinical Cancer Center
1240 Lee Street
Charlottesville, VA 22903
434.924.9333

Need Help Contacting This Doctor?

Dr. Ryan Gentzler is a thoracic oncologist at the University of Virginia Cancer Center and assistant professor. Dr. Gentzler’s has a clinical focus on the treatment of patients with lung cancer and other thoracic malignancies, including mesothelima. He also has experience treating esophageal cancer and cancers of the head and neck.

Dr. Gentzler has authored and co-authored over a dozen medical studies. His research is centered around the development of novel therapies for lung cancer, with a focus on immunotherapy drugs. He serves as the principle investigator on several clinical trials, and actively works to develop and add new clinical trials for patients in the area to provide access to more promising emerging treatments.

Main Specialty: Hematology, Oncology

Other Interests & Specialties: General oncology, hematologic oncology, lung cancer and other thoracic malignancies, esophageal cancers, head and neck cancers and immune-based therapies.

Certifications, Awards & Accolades: American Board of Internal Medicine Certifications in Internal Medicine and Medical Oncology, Emmanuel M. Weinberger Award for Outstanding Achievement in Hematology/Oncology, Kowlessar Award, Excellence in Teaching Award, Compassionate Care Award

Education & Experience:

Publications:
24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. January 2019;14(1):124-129. doi: 10.1016/j.jtho.2018.08.004

Indoleamine-2,3-Dioxygenase in Non-Small Cell Lung Cancer: A Targetable Mechanism of Immune Resistance Frequently Coexpressed With PD-L1. American Journal of Surgical Pathology. September 2018;42(9):1216-1223. doi: 10.1097/PAS.0000000000001099

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. Lancet Oncology. November 2016;17(11):1497-1508. doi: 10.1016/S1470-2045(16)30498-3

Author: Linda Molinari

Editor in Chief, Mesothelioma Cancer Alliance

Linda Molinari

Reviewer: Annette Charlevois

Patient Support Coordinator

Annette Charlevois
Share
Tweet
Share
Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide